Private Equity, VC & Investor
Greenoaks vs Vision Fund (SoftBank Vision Fund)
Structured technology and market comparison · 2026
Direct Feature Comparison
Greenoaks · vs · Vision Fund (SoftBank Vision Fund)Concentrated long-term venture investor in technology businesses.
Large technology investment fund platform managed by SoftBank subsidiaries.
Analyze all overlapping signals and tech stacks for Greenoaks and Vision Fund (SoftBank Vision Fund)
Compare mutual enterprise clients, monetization models, live market signals, and partner networks directly in the interactive Knowledge Graph.
Comparison Analysis
What is the main difference between Greenoaks and Vision Fund (SoftBank Vision Fund)?
When comparing Greenoaks and Vision Fund (SoftBank Vision Fund), both platforms operate within the Private Equity, VC & Investor ecosystem. Greenoaks is positioned as Concentrated long-term venture investor in technology businesses, whereas Vision Fund (SoftBank Vision Fund) focuses on Large technology investment fund platform managed by SoftBank subsidiaries. Decision-makers evaluate both solutions when orchestrating their commercial monetization and technology stack.
What are the top alternatives to Greenoaks and Vision Fund (SoftBank Vision Fund)?
When evaluating Greenoaks and Vision Fund (SoftBank Vision Fund), enterprise buyers also consider other platforms in Private Equity, VC & Investor. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.
How do the corporate scale, structure, and headquarters of Greenoaks and Vision Fund (SoftBank Vision Fund) compare?
Greenoaks is headquartered in United States (founded in 2012) with 10–49 employees. Vision Fund (SoftBank Vision Fund) is based in United Kingdom (founded in 2017) with 201–500 employees. Complete ownership, subsidiary trees, and corporate affiliations are documented across Polaris7.
Market Signals
Recent Market Signals & Activity: Greenoaks vs Vision Fund (SoftBank Vision Fund)
Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.
Greenoaks
Recent Signals
- ·CNBC TechnologyPrivacy
Coupang dispute raises U.S. tariff pressure on South Korea
A Republican-led House Judiciary report alleges the South Korean government mounted a targeted campaign against U.S.-headquartered Coupang after a 2025 data breach, prompting calls from some U.S. lawmakers and investors for formal trade investigations and potential tariffs. South Korea disputes the report, defends its actions and the scale of the breach, and says it has engaged with U.S. officials. Investors including Greenoaks and Altimeter urged the U.S. Trade Representative to open a Section 301 probe. The dispute comes amid broader U.S.-South Korea tensions over trade commitments, security cooperation and earlier tariff actions.
- House Judiciary Committee Republicans released a report alleging the South Korean government waged a targeted offensive against Coupang following a data breach.
- South Korea levied a 625 billion won (about $409 million) data-privacy fine on Coupang; Seoul says the breach affected 37.55 million people.
- Investors Greenoaks Capital Partners and Altimeter Capital petitioned the U.S. Trade Representative in January to open a Section 301 investigation into South Korea over its treatment of Coupang.
- ·AINews swyxBehavioral simulation and synthetic populations for decision-making
Simile AI: Behavioral Simulation and Scaling Laws
This podcast episode with Simile co-founder and CEO Joon Sung Park explores the company's work building behavioral foundation models and synthetic populations for simulation. Simile has raised over $300 million at a $2 billion valuation, backed by a recent Series B. The company creates digital twins from interviews, transaction/observational data, and randomized controlled trials, enabling enterprise clients like CVS Health to test policies on simulated populations. In a 1,000-person study, digital twins reproduced human behavior about 85% as accurately as the originals. Simile has partnered with Gallup to access tens of millions of real human subjects, and aims to scale from market research and legal strategy to societal-level simulations of 'wicked problems' like climate change. The episode also discusses the company's multi-agent simulations and its long-term vision.
- Simile has raised over $300 million at a $2 billion valuation (reported Series B).
- Simile creates digital twins of real people from interviews and behavioral data, used by Fortune 100 clients like CVS.
- In a representatively sampled 1,000-person study, Simile's digital twins reproduced human behavior about 85% as accurately as the original humans.
Vision Fund (SoftBank Vision Fund)
Recent Signals
No recent market signals documented for Vision Fund (SoftBank Vision Fund) in the current tracking window.
Compare their exact ecosystem overlaps.
Explore all deep relationships in Polaris7. Discover exactly which mutual clients, integrated technologies, and overlapping partners Greenoaks and Vision Fund (SoftBank Vision Fund) share across the market ecosystem.
Unlock full capability matrix, client overlaps & technology stacks